Encyclopedia of Pharmacy Practice and Clinical Pharmacy covers definitions, concepts, methods, theories and applications of clinical pharmacy and pharmacy practice.

Table of Contents

• Editor Biographies
• Foreword
• Preface
• Dedication
• List of Contributors to Part 1
• List of Contributors to Part 2
• List of Contributors to Part 3—Part A
• List of Contributors to Part 3—Part B
• Part 1
• Pharmacy Practice Research Methods
• — Pharmacy Practice and Its Research: Evolution and Definitions
• — Research Designs and Methodologies Related to Pharmacy Practice
• — Quantitative Methods in Pharmacy Practice Research
• — Qualitative Methods in Pharmacy Practice Research
• — Meta-Synthesis of Qualitative Research in Pharmacy Practice
• — Mixed Methods Research in Pharmacy Practice: Basics and Beyond
• — Publication Bias
• — Discrete Choice Experiment
• — Quality of Qualitative Research
• — Clinical Pharmacists as Principal Investigators in Clinical Trials
• — Evidence-Based Pharmacy Practice Research in Low- and Middle-Income Countries: Issues, Challenges and Synthesis
• — Implementation Science
• — Network Meta-Analysis in Pharmacy Practice Research
• — Ethnography in Pharmacy Policy and Practice
• — Philosophical Perspectives and Theories Applied in Pharmacy Practice Research
• — Principles, Paradigms, and Application of Qualitative Research in Pharmacy Practice
• Pharmacy Practice
• — Medicines Management: The Core of Pharmacy Practice
• — Historical Evolution of Pharmacy Practice
• — Codes of Conduct/Ethics in Pharmacy Practice
• — Community and Ambulatory Pharmacy Practice
• — Hospital Pharmacy Practice: A Case Study from Canada
• — Expanded and Evolving Roles for Pharmacists
• — Professional Pharmacy Services
• — Prescribing: Practices, Standards, Ethics, Behaviors, and Competencies: A Case Study in Alberta
• — Professionalism in Pharmacy Practice
• — Regulating Pharmacy Professionals
• — Public Health and Health Promotion in Pharmacy Practice
• — Collaborative and Interprofessional Pharmacy Practice
• — Interpersonal Communication in Pharmacy Practice
• — Evidence-Based Medicine: An Overview for Pharmacists
• — Patient Counseling and Education: Models and Methods in Pharmacy Practice
• — Technology and Social Media Applications in Pharmacy Practice
• — Pediatric Pharmacy Practice
• — Use of Complementary/Alternative Medicines in Pharmacy Practice
• — Prevention and Management of Substance Misuse and Addiction in Pharmacy Practice
• — Self-Care/Over-the-Counter Drugs/Minor Ailments in Pharmacy Practice
• — Extemporaneous Compounding in Pharmacy Practice
• — Global Health and Pharmacy Practice
• — Pharmacy Practice in the UK
• — Pharmacy Practice in Western Europe
• — Pharmacy Practice in Australia and New Zealand
• — Pharmacy Practice in China
• — Pharmacy Practice in India
• — Pharmacy Practice in the Gulf States
• — Pharmacy: A Business, A Profession, Both, or Neither?
• — Pharmacy Practice in the Philippines
• — Pharmacy Practice in Primary and Secondary Care Settings Within the UK: An In-Depth Analysis
• — Pharmacy Practice in Portugal
• Part 2
• — What is Social Pharmacy?
• — Access to Biosimilars
• — High-Cost Medicines: Access, Affordability, and Prices
• — Medication Adherence
• — Aging Populations and Medicine Use: A Sociological Approach
• — Who Are We?—The Evolving Professional Role and Identity of Pharmacists in the 21st Century
• — Counterfeit Medicines: A Quick Review on Crime Against Humanity
• — The Impact of Culture and Religion on Medicine Use
• — Disease Mongering: Corporate Greed and the Creation of Disease
• — Factors Influencing Pharmaceutical Policy Implementation
• — Funding Mechanisms for Community Pharmacy Service Provision
• — Generic Drug Policies
• — The Social Determinants of Health Inequalities: Implications for Research and Practice in Social Pharmacy
• — Managing Cultural Diversity in Pharmacy Practice in the United States
• — Marketing of Pharmacy Services
• — Medication Narratives
• — National Medicine Policies Impacting on Pharmacy Practice
• — Pharmaceutical Company Sponsored Medication Assistance Programs
• — Pharmaceutical Pricing Policies
• — Development of the Theoretical Concept of Pharmaceuticalization
• — Technology and Pharmacy: Theory, Practice, and the Future Vision
• — Public and Patient Engagement
• — Sociology for Pharmacists
• — Essential Medicine List, Policies, and the World Health Organization
• — Implementation of Change in Pharmacy Practice
• — Professional Boundaries
• — Drug Misuse and Dependence: The Role of Community Pharmacy
• — Corporatization of Community Pharmacy
• — Stigma Surrounding Medicine Use—HIV Exemplar
• — External Reference Pricing and Medicines
• — Pharmacy Workforce Development: A Global Pathway to Gender and Health Equity
• — Role of Pharmacists in Responding to Humanitarian Crisis
• — Strengthening Health Systems in Low and Middle-Income Countries Through Evaluating Cancer Medicine Prices, Availability and Affordability: A Case Study and Proposal
• — Definitions, Principles, and Concepts of Pharmacoepidemiology and Pharmacovigilance
• — Descriptive and Drug Utilization Studies
• — Case-Control Studies
• — Cohort Studies—A Brief Overview
• — Methodological Challenges in Epidemiological Studies
• — Sources of Data Used in Pharmacoepidemiology and Pharmacovigilance
• — Special Population Studies to Inform Medication Safety—Pediatrics
• — Comparative Effectiveness Research
• — Economic Evaluation of Pharmaceuticals
• — Methodological Considerations in Pharmacoepidemiology and Pharmacovigilance Studies
• — Application of Pharmacoepidemiology and Pharmacovigilance Studies
• Part 3A
• — Professional Ethics in Pharmacy Clinical Governance
• — Clinical Pharmacokinetic Principles and Therapeutic Drug Monitoring
• — Clinical Pharmacy Practice: Concepts, History, and Development
• — Development of Therapeutic Guidelines
• — End-of-Life Care Including Pharmaceuticals in Palliative Care
• — Fundamentals of Pharmaceutical Care Planning
• — Health Outcomes and Quality of Life
• — Military Pharmacy Practice Around the World and the Role of the Pharmacy Officer
• — Role of Pharmacist in Provision of Clinical Services in Prisons
• — Long-Term Care
• — Prescribing Insulin for People With Diabetes in Secondary Care: Recommendations and Future Direction
• — Pharmacotherapy and Deprescribing
• — Management of Cardiovascular Disorders and the Pharmacist's Role: Hypertension
• — Acute Coronary Syndrome
• — Management of Coronary Artery Disease & Dyslipidemia and Pharmacist's Role
• — Management of Cardiovascular Disorders and the Pharmacist's Role: Heart Failure
• — Management of Cerebrovascular Disease and the Pharmacist's Role: Stroke
• — Management of Cardiovascular Disorders and the Pharmacist's Role: Venous Thromboembolism
• — Management of Respiratory Disorders and the Pharmacist's Role: Asthma
• — Management of Respiratory Disorders and the Pharmacist's Role: COPD
• — Management of Respiratory Disorders and the Pharmacist's Role: Cough, Colds, and Sore Throats and Allergies (Including Eyes)
• — Management of Respiratory Disorders and the Pharmacist's Role: Cystic Fibrosis
• — Management of Gastrointestinal Disorders and the Pharmacist's Role: Coeliac Disease
• — Constipation
• — Management of Gastrointestinal Disorders and the Pharmacist's Role: Gastroesophageal Reflux Disease
• — Management of Gastrointestinal Disorders and the Pharmacist's Role: Inflammatory Bowel Disease
• — Management of Gastrointestinal Disorders and the Pharmacist's Role: Nausea and Vomiting
• — Management of Gastrointestinal Disorders and the Pharmacist's Role: Peptic Ulcer Disease
• — Management of Renal Disorders and the Pharmacist's Role: Acute Kidney Injury
• — Management of Renal Disorders and the Pharmacist's Role: Chronic Kidney Disease
• — Management of Endocrine Disorders and the Pharmacist's Role: Adrenal Insufficiency
• — Management of Endocrine Disorders and the Pharmacist's Role: Diabetes
• — Management of Endocrine Disorders and the Pharmacists’ Role: Thyroid Disorders
• — Contraception and the Pharmacist's Role
• — Management of Urologic Disorders and the Pharmacist's Role: Benign Prostatic Hyperplasia
• — Management of Erectile Dysfunction and the Pharmacist's Role
• — Management of Urologic Disorders and the Pharmacist's Role in Urinary Incontinence
• — Management of Rheumatology Disorders and the Pharmacist's Role: Gout and Related Conditions
• — Management of Rheumatology Disorders and the Pharmacist's Role: Osteoporosis
• — Management of Rheumatoid Arthritis and the Pharmacist's Role
• — Management of Eye and Ear Disorders and the Pharmacist's Role: Glaucoma
• — Management of Eye Disorders and the Pharmacist's Role: Eye Infections
• — Epilepsy: Management of Neurological Disorder and the Pharmacist's Role
• — Management of Neurological Disorders and Pharmacist's Role: Multiple Sclerosis
• — Attention-Deficit Hyperactivity Disorder Management and the Role of the Pharmacist
• — Anxiety Disorders
• — Bipolar Affective Disorder
• — Major Depressive Disorder
• — Management of Mental Health Disorders and the Pharmacist's Role: Schizophrenia
• — Acne Vulgaris
• — Management of Dermatology Disorders and the Pharmacist's Role: Acne, Psoriasis, Atopic Dermatitis, and Fungal Infections
• — Management of Infectious Diseases and the Pharmacist's Role—Antibiotic Stewardship
• — Bacterial Infections and the Role of the Pharmacist
• — Management of Infectious Diseases and the Pharmacist's Role: Fungal Infections
• — Pharmacotherapy of Viral Infections and the Role of Pharmacists in the Prevention and Treatment of Viral Diseases
• — Nutritional Anemias
• — Clinical Pharmacy Considerations in Special Population: Drug Dose Adjustment in Hepatic Impairment
• — Clinical Pharmacy Considerations in Special Populations: Geriatrics
• — Clinical Pharmacy Considerations in Special Population: Pediatrics
• — Clinical Pharmacy Considerations in Special Population: Pregnancy and Lactation
• — Clinical Pharmacy Considerations in ICU
• — Irritable Bowel Syndrome (IBS)
• — Management of Wounds and the Pharmacist's Role: Woundcare
• — Direct Oral Anticoagulants and the Patient-Reported Outcomes: Synthesis and Advances
• Part 3B
• — Becoming A Pharmacist: Education and Training—A Stepwise Approach to Competency-Based Pharmacy Education
• — Becoming a Pharmacy Assistant and Technician: Education and Training
• — Certification, Credentialing, and Privileging in Clinical Pharmacy
• — Clinical Pharmacy Professional Standards in European Union
• — Clinical Pharmacy Professional Standards in Low- and Middle-Income Countries
• — Clinical Pharmacy Professional Standards in United States of America and Canada
• — Competency Standards for Clinical Pharmacists
• — Continuing Professional Development for Clinical Pharmacists
• — Evaluating and Developing Clinical Skills
• — Dynamic Relationship Between Education, Regulation, and Practice
• — Experiential Education for Clinical Pharmacists
• — Indicators of Quality of the Patient Care in Hospital and Community Settings
• — Interprofessional Clinical Education
• — Leadership in Pharmacy
• — Learning and Teaching Methods to Develop Clinical Skills in Pharmacy
• — Needs-Based Education in Pharmacy
• — Developing and Implementing Patient Safety Standards Within the Pharmacy Practice and Education Settings
• — Pharmacy Professional Standards Defining Quality of Services
• — Professionalism as the Core Competency in Pharmacy
• — Quality Assurance and Quality Advancement of Pharmacy Education
• — Using Patients and Other Forms of Simulation in Teaching Clinical Skills
• — Pharmacist Workforce Issues
• — Pharmacometrics and its Application in Clinical Practice
• — Dynamic Relationship Between Education, Regulation, and Practice: Case Studies and Examples